Key result
Iron deficiency anemia is linked to increased pulmonary embolism risk, especially in type 2 diabetes.
Iron deficiency anemia may be an underrecognized contributing factor to the development of pulmonary embolism, particularly in patients with type 2 diabetes.
IDA may prompt PE vigilance in anemic T2DM patients; hypothesis-generating and requires prospective confirmation before practice change.
This case emphasizes iron deficiency anemia (IDA) as a potential risk factor for pulmonary embolism (PE), especially in patients with type 2 diabetes. Early recognition and management of PE and IDA are crucial. Further research is needed to clarify the mechanisms linking IDA to thrombosis and improve prevention strategies.
No takes yet. Share an insight, caveat, or question.
Yogeeta et al. (2025) studied this question. Iron deficiency anemia is a potential risk factor for pulmonary embolism, especially in patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: